These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37630545)

  • 21. Effect of COVID-19 Vaccination on the Levels of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Naive, Hybrid, and Breakthrough SARS-CoV-2 Recovered Indian Individuals.
    Deepika G; Adarsh S; Sadhana Y; Srihitha M; Veeraiah N; Reddy DN
    J Lab Physicians; 2023 Sep; 15(3):377-382. PubMed ID: 37564232
    [No Abstract]   [Full Text] [Related]  

  • 22. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
    Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
    Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.
    Rosati M; Terpos E; Ntanasis-Stathopoulos I; Agarwal M; Bear J; Burns R; Hu X; Korompoki E; Donohue D; Venzon DJ; Dimopoulos MA; Pavlakis GN; Felber BK
    Front Immunol; 2021; 12():793953. PubMed ID: 34899762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection.
    Haddad NS; Nguyen DC; Kuruvilla ME; Morrison-Porter A; Anam F; Cashman KS; Ramonell RP; Kyu S; Saini AS; Cabrera-Mora M; Derrico A; Alter D; Roback JD; Horwath M; O'Keefe JB; Wu HM; Ian Wong AK; Dretler AW; Gripaldo R; Lane AN; Wu H; Lee S; Hernandez M; Engineer V; Varghese J; Le S; Sanz I; Daiss JL; Eun-Hyung Lee F
    bioRxiv; 2020 Dec; ():. PubMed ID: 33299998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 antibody response dynamics and heterogeneous diagnostic performance of four serological tests and a neutralization test in symptomatic healthcare workers with non-severe COVID-19.
    Ong DSY; Keuren F; van der Vliet M; Boxma-de Klerk BM; Koeleman JGM
    J Clin Virol; 2021 Aug; 141():104904. PubMed ID: 34229209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods.
    Bošnjak B; Stein SC; Willenzon S; Cordes AK; Puppe W; Bernhardt G; Ravens I; Ritter C; Schultze-Florey CR; Gödecke N; Martens J; Kleine-Weber H; Hoffmann M; Cossmann A; Yilmaz M; Pink I; Hoeper MM; Behrens GMN; Pöhlmann S; Blasczyk R; Schulz TF; Förster R
    Cell Mol Immunol; 2021 Apr; 18(4):936-944. PubMed ID: 33139905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection.
    Gerhards C; Thiaucourt M; Kittel M; Becker C; Ast V; Hetjens M; Neumaier M; Haselmann V
    Int J Infect Dis; 2021 Jun; 107():221-227. PubMed ID: 33932604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 - A Comprehensive Analysis.
    Meyer B; Martinez-Murillo PA; Lemaitre B; Blanchard-Rohner G; Didierlaurent AM; Fontannaz P; Eugercios Manzanas C; Lambert PH; Loevy N; Kaiser L; Sartoretti J; Tougne C; Villard J; Huttner A; Siegrist CA; Eberhardt CS
    Front Immunol; 2022; 13():841009. PubMed ID: 35585978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of virus neutralization activity and results of 10 different anti-SARS-CoV-2 serological tests in COVID-19 recovered plasma donors.
    Szabó Z; Szabó T; Bodó K; Kemenesi G; Földes F; Kristóf K; Barabás E; Vásárhelyi B; Prohászka Z; Fodor E; Jakab F; Berki T; Lacza Z
    Pract Lab Med; 2021 May; 25():e00222. PubMed ID: 33898689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody Response to the SARS-CoV-2 Spike and Nucleocapsid Proteins in Patients with Different COVID-19 Clinical Profiles.
    Soares SR; da Silva Torres MK; Lima SS; de Sarges KML; Santos EFD; de Brito MTFM; da Silva ALS; de Meira Leite M; da Costa FP; Cantanhede MHD; da Silva R; de Oliveira Lameira Veríssimo A; Vallinoto IMVC; Feitosa RNM; Quaresma JAS; Chaves TDSS; Viana GMR; Falcão LFM; Santos EJMD; Vallinoto ACR; da Silva ANMR
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Puenpa J; Wanlapakorn N; Chirathaworn C; Sudhinaraset N; Sripramote M; Chalongviriyalert P; Jirajariyavej S; Kiatpanabhikul P; Saiyarin J; Soudon C; Thienfaidee O; Ayuthaya TPN; Brukesawan C; Intharasongkroh D; Chaiwanichsiri D; Issarasongkhram M; Kitphati R; Mungaomklang A; Thitithanyanont A; Nagavajara P; Poovorawan Y
    PLoS One; 2022; 17(4):e0267102. PubMed ID: 35446889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2.
    Deshpande GR; Kaduskar O; Deshpande K; Bhatt V; Yadav P; Gurav Y; Potdar V; Khutwad K; Vidhate S; Salunke A; Patil C; Shingade S; Jarande K; Tilekar B; Salvi P; Patsuthe S; Dange V; Kumar S; Gurav S; Chate S; Abraham P; Sapkal G
    Int J Infect Dis; 2021 Nov; 112():103-110. PubMed ID: 34543771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Shedding of SARS-CoV-2 Virus in COVID-19 Patients and Neutralizing Antibody Level].
    Ayhancı T; Toptan H; Özer YE; Uzar S; Enül H; Adıay C; Sarac F; Dheir H; Köroğlu M; Hasöksüz M; Altındiş M
    Mikrobiyol Bul; 2022 Jul; 56(3):416-431. PubMed ID: 35960235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia.
    Merid Y; Tekleselasie W; Tesfaye E; Gadisa A; Fentahun D; Abate A; Alemu A; Mihret A; Mulu A; Gelanew T
    Front Immunol; 2023; 14():1163688. PubMed ID: 37398668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals.
    Brochot E; Demey B; Touzé A; Belouzard S; Dubuisson J; Schmit JL; Duverlie G; Francois C; Castelain S; Helle F
    Front Microbiol; 2020; 11():584251. PubMed ID: 33193227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal Assessment of SARS-CoV-2 Antinucleocapsid and Antispike-1-RBD Antibody Testing Following PCR-Detected SARS-CoV-2 Infection.
    El-Khoury JM; Schulz WL; Durant TJS
    J Appl Lab Med; 2021 Jul; 6(4):1005-1011. PubMed ID: 33822964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative evaluation of SARS-CoV-2 IgG assays against nucleocapsid and spike antigens.
    Rezaei M; Sadeghi M; Korourian A; Tabarsi P; Porabdollah M; Askari E; Mortaz E; Mahmoudi S; Marjani M; Velayati AA
    Hum Antibodies; 2021; 29(2):109-113. PubMed ID: 33720878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.